Inhibition of glycogen synthase kinase 3β activity regulates proliferation of cultured cerebellar granule cells

Developmental Brain Research

Volumn 111, Issue 2, 1998, Pages 177-188

  Cui, Hong ^a   Meng, Ying ^a   Bulleit, Robert F ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebellar granule neuron progenitors; Glycogen synthase kinase 3; Insulin like growth factor I; Mitogen; Phosphoinositide 3 kinase; Proliferation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GRANULE CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIMANIC AGENTS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELLS, CULTURED; CEREBELLUM; CHROMONES; DIPHOSPHONATES; ENZYME INHIBITORS; FLAVONOIDS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; INSULIN-LIKE GROWTH FACTOR I; LITHIUM CHLORIDE; MICE; MICE, INBRED STRAINS; MITOGENS; MORPHOLINES; NEURONS; STEM CELLS; THYMIDINE; TRITIUM;

ANIMALIA;

EID: 0032495107     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(98)00136-9     Document Type: Article

References (61)

1. Abdallah B., Hassan A., Boneist H., Goula D., Behr H.P., Demeneix B.A. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Human Gene Therapy. 7:1996;1947-1954.
2. Arcaro A., Wymann M.P. Wortmannin is a potent phosphotidylinositol 3-kinase inhibitor: the role of phosphotidylinositol 3,4,5-triphosphate in neurotrophil responses. Biochem J. 296:1993;297-301.
3. Bach M.A., Shen-Orr Z., Lowe W.L. Jr., Roberts C.T. jr., LeRoith D. Insulin-like growth factor I RNA levels are developmentally regulated in specific regions of the rat brain. Mol. Brain Res. 10:1991;43-48.
4. Beck K.D., Powell-Braxton L., Widmer H., Valverde J., Heft F. IGF1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron. 14:1995;717-730.
5. Berridge M.J., Downes C.P., Hanley M.R. Neural and developmental action of lithium: a unifying hypothesis. Cell. 59:1989;411-419.
6. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA. 92:1995;7297-7301.
7. Burgering B.M.T., Coffer P.J. Protein kinase B (cAkt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:1995;599-602.
8. Coolican S.A., Samuel D.S., Ewton D.Z., McWade F.J., Florini J.R. The mitogenic and myogenic action of insulin-like growth factor utilizes distinct signaling pathways. J. Biol. Chem. 272:1997;6653-6662.
9. Cross D.A., Alessi D.R., Vandenheede J.R., McDowell H.E., Hundal H.S., Cohen P. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J. 303:1994;21-26.
10. Cross D.A., Alessi D.R., Cohen P., Anduelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:1995;785-789.
11. Cui H., Bulleit R.F. Potassium chloride inhibits proliferation of cerebellar granule neuron progenitors. Dev. Brain Res. 106:1998;129.
12. Dickinson M.E., Krumlauf R., McMahon A.P. Evidence for a mitogenic effect of Wnt-1 in the developing mammalian central nervous system. Development. 120:1994;1453-1471.
13. DiCicco-Bloom E., Black I.B. Insulin growth factor regulates the mitotic cycle in cultured rat sympathetic neuroblasts. Proc. Natl. Acad. Sci. USA. 85:1988;406-4070.
14. D'Mello S.R., Gallo C., Ciotti T., Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA. 90:1993;10989-10993.
15. Drago J., Murphy M., Carroll S.M., Harvey R.P., Bartlett P.F. Fibroblast growth factor-mediated proliferation of central nervous system precursors depend on endogenous production of insulin-like growth factor I. Proc. Natl. Acad. Sci. USA. 88:1991;2199-2203.
16. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:1997;661-665.
17. Dudley D., Pang L., Decker S., Bridges A., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:1995;7686-7689.
18. Dufourny B., Alblas J., van Teeffelen H.A.A.M., van Schaik F.M.A., van de Burg B., Steenbergh P.H., Sussenbach J.S. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J. Biol. Chem. 272:1997;31163-31171.
19. Eldar-Finkelman H., Krebs E.G. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc. Natl. Acad. Sci. USA. 94:1997;9660-9664.
20. Eldar-Finkelman H., Seger R., Vandenheede J.R., Krebs E.G. Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J. Biol. Chem. 270:1995;987-990.
21. Eldar-Finkelman H., Argast G.M., Foord O., Fischer E.H., Krebs E.G. Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells. Proc. Natl. Acad. Sci. USA. 93:1996;10228-10233.
22. Fredieu J.R., Cui Y., Maier D., Danilchik M.V., Christian J.L. Xwnt-8 and lithium can act upon either dorsal mesodermal or neurectodermal cells to cause a loss of forebrain in xenopus embryos. Dev. Biol. 186:1997;100-114.
23. Fujita S. Quantitative analysis of cell proliferation and differentiation in the cortex of the postnatal mouse cerebellum. J. Cell Biol. 32:1967;277-287.
24. Gavin B.J., McMahon J.A., McMahon A.P. Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development. Gene Dev. 4:1990;2319-2332.
25. Gao W.Q., Heintz N., Hatten M. Cerebellar granule cell neurogenesis is regulated by cell-cell interactions in vitro. Neuron. 6:1991;705-715.
26. Gao W.Q., Zheng J.L., Karihaloo M. Neurotrophin-4/5 (NT4/5) and brain-derived neurotrophic factor (BDNF) act at later stages of cerebellar granule cell differentiation. J. Neurosci. 15:1995;2656-2667.
27. Hatten M.E. Neuronal regulation of astroglial morphology and proliferation in vitro. J. Cell Biol. 100:1985;384-396.
28. Hamilton S.R., Liu B., Parsons R.E., Papadopoulos N., Jen J., Powell S.M., Krush A.J., Berk T., Cohen Z., Tetu B., Burger P.C., Wood P.A., Taqi F., Booker S.V., Petersen G.M., Offerhaus G.J.A., Tersmette A.C., Giardiello F.M., Vogelstein B., Kinzler K.W. The molecular basis of Turcot's syndrome. New Eng. J. Med. 332:1995;839-847.
29. Hedgepeth C.M., Conrad L.J., Zhang J., Huang J.C., Lee V.M.Y., Klein P.S. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol. 185:1997;82-91.
30. Humbel R.E. Insulin-like growth factor I and II. Eur. J. Biochem. 190:1990;445-462.
31. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16:1995;3-34.
32. 125I] insulin receptor binding sites in developing and adult rat brain J. Comp. Neurol. 333:1993;375-397.
33. Kato H., Faria T.N., Stannard B., Roberts T., LeRoit D. Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). J. Biol. Chem. 268:1993;2655-2661.
34. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA. 93:1996;8455-8459.
35. Korinek V., Barker N., Morin P.J., van Wichen K., de Weger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a b-catenin-Tcf complex in APC-/- colon carcinoma. Science. 275:1997;1784-1787.
36. Lee W., Javedan S., Bondy C.A. Coordinate expression of insulin-like growth factor system components by neurons and neuroglia during retinal and cerebellar development. J. Neurosci. 12:1992;4737-4744.
37. Lin X., Bulleit R.F. Insulin-like growth factor (IGF-I) is a critical trophic factor for developing cerebellar granule cells. Dev. Brain Res. 99:1997;234-243.
38. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
39. Mares V., Lodin Z., Srajer J. The cellular kinetics of the developing mouse cerebellum: I. The generation cycle, growth fraction and rate of proliferation of the external granular layer. Brain Res. 23:1970;323-342.
40. McMahon A.P. The wnt-family of developmental regulators. Trends Genet. 8:1992;236-242.
41. Miale I.l., Sidman R.L. An autoradiographic analysis of histogenesis in the mouse cerebellum. Neurology. 4:1961;277-296.
42. Miller J.R., Moon R.T. Signal transduction through β-catenin and specification of cell fate during embryogenesis. Gene Dev. 10:1996;2527-2539.
43. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science. 275:1997;1787-1790.
44. Munemitsu S., Albert I., Souza B., Rubinfeld B., Polakis P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA. 92:1995;3046-3050.
45. Myers M.G. Jr., White M.F. Insulin signal transduction and the IRS protein. Annu. Rev. Pharmacol. Toxicol. 36:1996;615-658.
46. Nakamura Y. Cleaning up on β-catenin. Nature Med. 3:1997;499-500.
47. Pang L., Sawada T., Decker S.J., Saltiel A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:1995;13535-13588.
48. Plyte S.E., Hughes K., Nikolakaki K., Pulverer B.J., Woodgett J.R. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochimica et Biophysica Acta. 1114:1992;147-162.
49. Rubinfeld B., Robbins P., El-Gamil M., Albert I., Porfiri E., Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science. 275:1997;1790-1792.
50. Smeyne R.J., Chu T., Lewin A., Bian F., Crisman S.S., Kunsch C., Lira S.A., Oberdick J. Local control of granule cell generation by cerebellar purkinje cells. Mol. Cell Neurosci. 6:1995;230-251.
51. Ullrich A., Bell J.R., Chen E.Y., Herrera R., Petruzzelli L.M., Dull T.J., Gray A., Coussens L., Liao Y.C., Toubokawa M., Masson A., Seeberg P.H., Grunfeld C., Rosen O.M., Ramachandran J. Human insulin and its relationship to the tyrosine kinase family of oncogenes. Nature. 313:1995;756-761.
52. Van Obberghen E. Signalling through the insulin receptor and the insulin-like growth factor-I receptor. Diabetologia. 37:1994;S125-S134. Suppl. 2.
53. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase 2-(4-morphoinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:1994;5241-5248.
54. Vlahos C.J., Matter W.F., Brown R.F., Traynor-Kaplan A.E., Heyworth P.G., Prossnitz E.R., Ye R.D., Marder P., Schelm J.A., Rothfuss K.J.et al. Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. J. Immunology. 154:1995;2413-2422.
55. Volonte C., Ciotti M.T., Battistini L. Development of a method for measuring cell number: application to CNS primary neuronal cultures. Cytometry. 17:1994;274-276.
56. Welsh G.I., Proud C.G. Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem. J. 294:1993;625-629.
57. Welsh G.I., Wilson C., Proud C.G. GSK3: a SHAGGY frog story. Trends Cell Biol. 6:1996;274-279.
58. Welsh G.I., Patel J.C., Proud C.G. Peptide substrate suitable for assaying glycogen synthase Kinase-3 in crude cell extracts. Anal. Biochem. 244:1997;16-21.
59. Weoshons W.V., Engler K.S., Taylor J.A., Grady L.H., Curran E.M. Lithium-stimulated proliferation and alteration of phosphoinositide metabolites in MCF-7 human breast cancer cells. J. Cell Physiol. 165:1995;134-144.
60. Ye P., Carson J., D'Ercole A.J. In vivo actions of insulin-like growth factor-1 (IGF-1) on brain myelination: studies of IGF-1 and IGF-1 binding protein-1 (IGFBP-1) transgenic mice. J. Neurosci. 15:1995;7344-7356.
61. Ye P., Xing Y., Dai Z., D'Ercole A.J. In vivo actions of insulin-like growth factor-I (IGF-I) on cerebellum development in transgenic mice: evidence that IGF-I increases proliferation of granule progenitors. Dev. Brain Res. 95:1996;44-54.